BioCatalystWatch
ANIPWorkspace / ANIP / OverviewCompany library
ANI PHARMACEUTICALS INC logo

ANI PHARMACEUTICALS INC

ANI PHARMACEUTICALS INC (ANIP)

Website

Price
Market cap
Next catalystJan 21, 2027ILUVIEN · Phase 4 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Approved / commercial

ILUVIEN

Approved

PreINDP1P2P3FilingApproved
OXISTAT

Approved

PreINDP1P2P3FilingApproved
OXISTAT

Approved

PreINDP1P2P3FilingApproved
OXISTAT

Approved

PreINDP1P2P3FilingApproved
VEREGEN

Approved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ANIP PR & News

PR & News

ANIP SEC archive